Yusuke Satoh

This inventor holds 4 USPTO granted patents. Top assignees: Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Pharmaka Mbh, Aventis Pharma S.a., Biopharm Gesellschaft Zur Biotechnologieschen Entwicklung Von Pharmaka Mbh. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yusuke Satoh. Retrieved from https://idiyas.com/inventor/yusuke-satoh-imw17z69

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 50.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 17(Granted Patents)

Company Filing History:

2 out of 2

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Pharmaka Mbh

Biopharm Gesellschaft Zur Biotechnologieschen Entwicklung Von Pharmaka Mbh

patent

Years Active: 2002-2010

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7816103 - Protein and process for preparing the same (2010-10-19),

2. 7268114 - Protein and process for preparing the same (2007-09-11),

3. 7235527 - Protein and process for producing the same (2007-06-26),

4. 6498164 - Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same (2002-12-24),

Title: Yusuke Satoh: Innovator in Protein Engineering

Introduction

Yusuke Satoh is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of protein engineering, particularly in the development of proteins for pharmaceutical applications. With a total of 4 patents to his name, Satoh's work is recognized for its potential impact on treating cartilage and bone diseases.

Latest Patents

Among his latest patents is a groundbreaking invention related to a protein derived from human MP52. This invention details a homodimer protein that can be obtained through a series of sophisticated processes, including the construction of a plasmid and the purification of monomer proteins. The resulting homodimer protein is noted for its utility as a pharmaceutical composition aimed at treating cartilage and bone diseases.

Career Highlights

Yusuke Satoh has worked with notable companies in the biotechnology sector, including Biopharm Gesellschaft zur Biotechnologischen Entwicklung Pharmaka GmbH and Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka GmbH. His experience in these organizations has contributed to his expertise in protein development and biotechnology.

Collaborations

Throughout his career, Satoh has collaborated with esteemed colleagues such as Fusao Makishima and Hiroyuki Takamatsu. These partnerships have fostered innovation and advancement in the field of protein engineering.

Conclusion

Yusuke Satoh's contributions to protein engineering and his innovative patents highlight his role as a key figure in biotechnology. His work continues to pave the way for advancements in medical treatments for cartilage and bone diseases.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]